Globe Life (NYSE:GL) Given New $195.00 Price Target at JPMorgan Chase & Co.

Globe Life (NYSE:GL) had its price target boosted by equities research analysts at JPMorgan Chase & Co. from $193.00 to $195.00 in a research note issued on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 16.54% from the company’s current price.

Other analysts have also recently issued reports about the company. TD Cowen upped their price target on Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a research note on Wednesday, July 22nd. Jefferies Financial Group lifted their price objective on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research note on Friday, July 10th. Weiss Ratings lowered shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, October 6th. Piper Sandler boosted their price objective on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. Finally, Morgan Stanley lowered their target price on shares of Globe Life from $208.00 to $197.00 and set an “overweight” rating for the company in a research note on Monday, October 5th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $189.56.

Globe Life Trading Down 0.1%

NYSE GL traded down $0.09 on Thursday, reaching $167.32. The company had a trading volume of 32,519 shares, compared to its average volume of 538,045. Globe Life has a 52 week low of $127.85 and a 52 week high of $191.55. The stock’s 50 day moving average is $172.11 and its 200-day moving average is $166.02. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. The stock has a market cap of $12.86 billion, a price-to-earnings ratio of 11.12 and a beta of 0.44.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%. The company had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter last year, the business posted $3.05 EPS. Globe Life’s quarterly revenue was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities analysts predict that Globe Life will post 15.70 earnings per share for the current year.

Globe Life declared that its board has authorized a stock buyback program on Monday, August 10th that allows the company to buy back $2.50 billion in shares. This buyback authorization allows the company to buy up to 17.7% of its shares through open market purchases. Stock buyback programs are often an indication that the company’s management believes its stock is undervalued.

Insiders Place Their Bets

In other Globe Life news, CEO James Darden sold 50,000 shares of the business’s stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $182.43, for a total value of $9,121,500.00. Following the completion of the transaction, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at approximately $10,663,215.93. The trade was a 46.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael Majors sold 37,000 shares of the stock in a transaction dated Wednesday, July 29th. The stock was sold at an average price of $178.64, for a total value of $6,609,680.00. Following the completion of the sale, the executive vice president owned 53,518 shares of the company’s stock, valued at $9,560,455.52. This trade represents a 40.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 143,650 shares of company stock valued at $25,793,717 in the last three months. Insiders own 2.11% of the company’s stock.

Institutional Trading of Globe Life

Large investors have recently bought and sold shares of the business. Amundi lifted its stake in Globe Life by 307.4% in the second quarter. Amundi now owns 162,223 shares of the company’s stock valued at $28,986,000 after buying an additional 122,402 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Globe Life during the second quarter worth $4,574,000. Sei Investments Co. increased its position in shares of Globe Life by 49.1% during the first quarter. Sei Investments Co. now owns 71,795 shares of the company’s stock worth $9,993,000 after acquiring an additional 23,632 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Globe Life during the second quarter worth $17,229,000. Finally, Bank of America Corp DE acquired a new stake in shares of Globe Life during the second quarter worth $121,638,000. 81.61% of the stock is owned by institutional investors.

Globe Life Company Profile

Globe Life Inc (NYSE: GL) is an insurance holding company that provides life and supplemental health insurance products to individuals and families in the United States. Its offerings include term and whole life insurance, mortgage protection coverage, accident and supplemental health policies, and Medicare supplement insurance.

The company distributes its products through a network of insurance agencies, independent agents, and direct-to-consumer channels. Its principal insurance businesses include Globe Life and Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, and Family Heritage Life Insurance Company.